Offenbartl K S, Christensen P, Gullstrand P, Prellner K
Int Arch Allergy Appl Immunol. 1986;79(1):45-8. doi: 10.1159/000233940.
In spite of long-term antibiotic prophylaxis and pneumococcal vaccination, there still exists a proportion of highly susceptible splenectomized or functionally hyposplenic patients at risk of contracting fatal overwhelming infections. We have studied the effect of gammaglobulin prophylaxis in experimental sepsis among splenectomized rats. Administration of 37.5 mg human gammaglobulin/kg body weight 24 h before challenge with 10(3) pneumococci resulted in the survival of 19 of 24 rats, in contrast to 1 of 24 controls. A dose of 19 mg/kg body weight was not protective (7 of 23 survived). However, treatment with penicillin 18 h after challenge in the gammaglobulin-pretreated group of animals saved 21 of 24 animals, although penicillin without gammaglobulin prophylaxis showed no effect. These data indicate that even relatively low circulating concentrations of specific antibody after gammaglobulin prophylaxis might nonetheless be adequate to render septic disease easier to treat.
尽管进行了长期的抗生素预防和肺炎球菌疫苗接种,但仍有一部分高度易感的脾切除或功能性脾功能低下患者有感染致命性暴发性感染的风险。我们研究了丙种球蛋白预防在脾切除大鼠实验性脓毒症中的作用。在用10³ 肺炎球菌攻击前24小时,给予37.5毫克人丙种球蛋白/千克体重,24只大鼠中有19只存活,而24只对照组大鼠中只有1只存活。19毫克/千克体重的剂量没有保护作用(23只中有7只存活)。然而,在丙种球蛋白预处理的动物组中,攻击后18小时用青霉素治疗挽救了24只动物中的21只,尽管没有丙种球蛋白预防的青霉素没有效果。这些数据表明,即使丙种球蛋白预防后循环中特异性抗体浓度相对较低,仍可能足以使脓毒症更易于治疗。